Better than ADCs? AstraZeneca bids for Bicyclic Peptides
AstraZeneca has signed a deal with Bicycle Therapeutics that could exceed €1B. The foundation is…
December 2, 2016 - 2 minutes
AstraZeneca has signed a deal with Bicycle Therapeutics that could exceed €1B. The foundation is…
Bicycle Therapeutics, a next generation biotherapeutics UK-based company developing first-in-class bicyclic peptides, announced that it…